MANGALAMNSEMangalam Drugs And Organics Limited· PharmaceuticalsHighNegative
Announced Tue, 17 Feb · 12:50 IST

Subsequent Bank Default Intimation under Para-A Sub Para 6 of Schedule III

Loan NpaCredit & Debt View source PDF

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Mangalam Drugs And Organics has informed the stock exchange about a subsequent default in repayment to a bank. The disclosure has been made under SEBI's Listing Regulations (Schedule III, Para A, sub-para 6), which mandates listed companies to intimate exchanges when they default on loan obligations. The term 'Subsequent' indicates this is a follow-up intimation, likely confirming continued non-payment or updating details of a previously disclosed default. The specific bank and outstanding amount are not mentioned in the headline.

Likely market impact

This is a negative signal for shareholders, indicating the company is struggling to repay its debt on time and may face further financial stress, higher borrowing costs, and potential rating downgrades.